Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 13, Issue 9, 1998, Pages 2294-2302

  Coen, Giorgio ^a,c   Ballanti, Paola ^a   Bonucci, Ermanno ^a   Calabria, Santo ^a   Centorrino, Micaela ^a   Fassino, Valeria ^a   Manni, Micaela ^a   Mantella, Daniela ^a   Mazzaferro, Sandro ^a   Napoletano, Ilaria ^a   Sardella, Daniela ^a   Taggi, Franco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b 1st Superiore di Sanita' ^*  (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

Adynamic bone disease; Bone alkaline phosphatase isoenzyme; Bone biopsy; Bone markers; C terminal telopeptide of collagen type I; Deoxypiridinoline; Intact PTH; Osteocalcin; Renal osteodystrophy; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; ALUMINUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BONE BIOPSY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMODIALYSIS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; ILIAC BONE; MALE; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; URINARY EXCRETION;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BIOPSY; BONE AND BONES; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PARATHYROID HORMONE; RENAL DIALYSIS; RENAL OSTEODYSTROPHY;

EID: 0010516414     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.9.2294     Document Type: Article

References (36)

1. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A. Saiphoo C, Fenton SS, Segre GV. The spectrum of bone disease in end-stage renal failure. An evolving disorder. Kidney Int 1993; 436-442
2. Ward MK, Fest TG, Ellis HA, Parkinson IS, Kerr DNS, Herrington J, Goods GL. Osteomalacic dialysis osteodystrophy: evidence for a water-borne aetiological agent, probably aluminium. Lancet 1978; 1: 841-845
3. Charon SA, Chavassieux PM, Chapuy MC, Boivin GY, Meunier PJ. Low rate of bone formation with or without histologic appearance of osteomalacia in patients with aluminium intoxication. J Lab Clin Med 1985; 106; 123-131
4. Mora Palma FJ, Ellis HA, Cook DB, Dewar JH, Ward MK, Wilkinson R, Kerr DNS. Osteomalacia in patients with chronic renal failure before dialysis or transplantation. Q J Med 1983; 207: 332-348
5. Coen G, Manni M, Addari O, Ballanti P, Pasquali M, Chicca S, Mazzaferro S, Napoletano I, Sardella D, Bonucei E. Metabolic acidosis and osteodystrophic bone disease in predialysis chronic renal failure: effect of calcitriol treatment. Miner Electrolyte Metab 1995; 21; 375-382
6. Hercz G, Pci Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton SS, Sherrard DJ. Aplastic osteodystrophy without aluminium: the role of 'suppressed' parathyroid function. Kidney Int 1993; 44: 860-866
7. Cocn G, Mazzaferro, S. Bone metabolism and its assessment in renal failure, Nephron 1994; 67: 383-401
8. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestemates the presence and severity of parathyroidmediated osseous abnormalities in uraemia. J Clin Endocrinol Metab 1992; 75: 145-150
9. Fournier A, Oprisiu R, Said S, Sechet A, Ghazali A, Marie A, El Esper I, Brazier M, Achard JM, Moriniere P. Invasive versus non invasive diagnosis of renal bone disease. Curr Opinion Nephrol Hypertens 1997; 6: 333-348
10. Garnero P, Delmas PD. Assessment of the serum levels of bone alkaline phosphatases with a new immunometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab 1993; 77: 1046-1053
11. Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Costantini S, Chicca S, DeMeo S, Perruzza I, Sardella D, Taggi F, Coen G. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy. Nephrol Dial Transplant 1995; 10: 52-58
12. Ureña P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drucke TB, DeVernejoul MC. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995; 10: 932-939
13. Price PA, Nishimoto SR. Radioimmunoassay for the vitamin K dependent protein of bone disease and its discovery in plasma. Proc Natl Acad Sci USA 1980; 77: 2234-2238
14. Bianco P, Ponzi A, Bonucci E. Basic and 'special' stains for plastic sections in bone marrow histopathology. with special reference to May-Grunwald-Giemsa and enzyme histochemistry. Basic Appl Histochem 1984; 28: 265-279
15. Maloney NAQ, Ott SM, Alfrey AC, Miller NL, Coburn JW, Sherrard DJ. Histological quantification of aluminium in iliac bone from patients with renal failure. J Lab Clin Med 1982; 99: 206-216
16. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluchc HH, Meunier PJ, Ott SM, Recker RP. Bone histomorphometry: standardization of nomenclature, symbols and units. Bone Miner 1987; 2: 595-610
17. Bonucci E, Ballanti P, DellaRocca C, Milani S, LoCascio V, Imbimbo B. Technical variability of bone histomorphometric measurements. Bone Miner 1990; 11: 177-197
18. Ballanti P, Bonucci E, DellaRocca C, Milani S, LoCascio V, Imbimbo B. Bone histomorphometric reference values in 88 normal Italian subjects. Bone Miner 1990; 11: 187-197
19. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni M, Bonucci E, Taggi F. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 1996; 11: 813-819
20. Morinière P, Cohen Solal M, Belbrik S, Sebert JL, Fournier A, Disappearance of aluminic bone disease in a long term asymptomatic dialysis population restricting Al(OH)3: emergence of an idiopathic adynamic bone disease. Nephron 1989; 56: 93-101
21. Kotz S, Johnson NL. Encyclopedia of Statistical Science. John Wiley & Sons. New York: 1982
22. Malluche HH, Faugère MC. Renal bone disease 1990: an unmet challenge for the nephrologist. Kidney Int 1990; 38: 193-211
23. Smith A J, Faugère MC, Abreo K, Fanti P, Julian B, Malluche HH. Aluminium-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis. Am J Nephrol 1986; 6: 275-283
24. Fournier A, Moriniere P, Cohen Solal ME, Boudaillez B, Achard JM, Marie A, Sebert JL. Adynamic bone disease in uraemia: may it be idiopathic ? Is it an actual disease? Nephron 1991; 58: 1-12
25. D'Haese PC, Couttenye MM, DeBroe ME. Diagnosis and treatment of aluminium bone disease. Nephrol Dial Transplant 1996; 11[Suppl 3]: 74-79
26. Ureña P, Kubrisly M, Mannstadt M, Hruby M, Tan MT, Silve C. Lacour B, Abou-Samra AB, Segre GV, Druke T. The renal PTH/PTHrP receptor is downregulated in rats with chronic renal failure. Kidney Int 1994; 45: 605-611
27. Tian J, Smogorzewski M, Kedcs L, Massry SG. PTH-PTHrP receptor mRNA is downregulated in chronic renal failure. Am J Nephrol 1994; 14: 41-46
28. Massry SG, Stein R, Garty J, Arieff AI, Coburn JW, Norman AW, Friedler RM. Skeletal resistance to the calcemic action of parathyroid hormone in uraemia: role of 1,25(OH)2D3. Kidney Int 1976; 9: 467-474
29. Qi Q, Monier-Faugère MC, Geng Z, Malluche HH. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis. Am J Kidney Dis 1995; 26: 836-844
30. Gerakis A, Hutchison AJ, Apostolou Th, Freemont AJ, Billis A. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis. Nephrol Dial Transplant 1996; 11: 2430-2438
31. Wang M, Hercz G, Sherrard DJ, Maloney NA, Segre GV, Pei Y. Relationship between intact 1-84 parathyroid hormone and bone histomorphometrc parameters in dialysis patients without aluminium toxicity. Am J Kidney Dis 1955; 26: 836-844
32. Couttenye MM, D'Haese PC, Vaan Hoof VO, Lemoniantou E, Goodman W, Verpooten GA, De Broe ME. Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 1065-1072
33. Brossard JH, Cloutier M, Ray L, Lepage R, Gascon-Barré M, D'Amour P. Accumulation of a non(1-84)molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure, importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996; 8: 3923-3929
34. Robins SP. Collagen cross-links in metabolic bone disease. Acta Orthop Scand 1995; 66 [Suppl 266], 171-175
35. Ureña P, Hruby M, Ferreira A, Ang KS, DeVernejoul MC. Plasma total versus bone alkaline phosphatase as markers of bone turnover in haemodialysis patients J Am Soc Nephrol 1996; 7: 506-512
36. Pei Y, Hercz G, Greenwood C, Sherrard D, Segre G, Manuel A, Saiphoo C, Fenton S. Non-invasive prediction of aluminium bone disease in hemo- and peritoneal dialysis patients. Kidney Int 1992; 41: 1374-1382